Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer

Diseases of the Esophagus

Volumn 25, Issue 6, 2012, Pages 527-534

  D'Journo, X B ^a   Ouattara, M ^a   Loundou, A ^b   Trousse, D ^a   Dahan, L ^b   Nathalie, T ^a   Doddoli, C ^a   Seitz, J F ^b   Thomas, P A ^a  

^a Hôpital Nord   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Esophageal cancer; Esophagectomy; Malnutrition; Surgery; Survival; Weight loss

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CANCER SURVIVOR; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; POSTOPERATIVE CARE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TRANSTHORACIC ESOPHAGECTOMY; WEIGHT REDUCTION;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MALNUTRITION; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84864991108     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01282.x     Document Type: Article

References (32)

1. Gebski V, Burmeister B, Smithers B M etal. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226-34.
2. Eloubeidi M A, Desmond R, Arguedas M R etal. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 2002; 95: 1434-43.
3. Mariette C, Piessen G, Briez N etal. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 2008; 247: 365-71.
4. D'Journo X B, Avaro J P, Michelet P etal. Extracapsular lymph node involvement is a negative prognostic factor after neoadjuvant chemoradiotherapy in locally advanced esophageal cancer. J Thorac Oncol 2009; 4: 534-9.
5. Hulscher J B, van Sandick J W, de Boer A G etal. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-9.
6. Martin L, Jia C, Rouvelas I, Lagergren P. Risk factors for malnutrition after oesophageal and cardia cancer surgery. Br J Surg 2008; 95: 1362-8.
7. Martin L, Lagergren J, Lindblad M, Rouvelas I, Lagergren P. Malnutrition after oesophageal cancer surgery in Sweden. Br J Surg 2007; 94: 1496-500.
8. Martin L, Lagergren P. Long-term weight change after oesophageal cancer surgery. Br J Surg 2009; 96: 1308-14.
9. D'Journo X B, Martin J, Ferraro P, Duranceau A. The esophageal remnant after gastric interposition. Dis Esophagus 2008; 21: 377-88.
10. Lagarde S M, de Boer J D, ten Kate F J, Busch O R, Obertop H, van Lanschot J J. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence. Ann Surg 2008; 247: 71-6.
11. Lerut T, Moons J, Coosemans W etal. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification. Ann Surg 2009; 250: 798-807.
12. Rizk N P, Bach P B, Schrag D etal. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 2004; 198: 42-50.
13. Yu W, Seo B Y, Chung H Y. Postoperative body-weight loss and survival after curative resection for gastric cancer. Br J Surg 2002; 89: 467-70.
14. Paccagnella A, Morassutti I, Rosti G. Nutritional intervention for improving treatment tolerance in cancer patients. Curr Opin Oncol 2011; 23: 322-30.
15. Gupta D, Lis C G, Vashi P G, Lammersfeld C A. Impact of improved nutritional status on survival in ovarian cancer. Support Care Cancer 2010; 18: 373-81.
16. Cincibuch J, Neoral C, Aujeský R etal. Prognostic factors in patients with esophageal carcinoma treated with chemoradiation: single center experience. Hepatogastroenterology 2010; 57: 1145-9.
17. Sobin L H, Wittekind C, (eds). TNM Classification of Malignant Tumours, 6th edn. Hoboken, NJ: John Wiley & Sons, 2002.
18. Siewert J R, Stein H J. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-9.
19. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. Geneva: WHO, 1998.
20. Rutegard M, Hughes R, Lagergren P, Blazeby M. Determinants of global quality of life before and after major cancer surgery: an exploratory study. Qual Life Res 2009; 18: 1131-6.
21. Langenhoff B S, Krabbe P F M, Wobbes T etal. Quality of life as an outcome measure in surgical oncology. Br J Surg 2001; 88: 643-52.
22. Djärv T, Lagergren P. Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgery. Eur J Cancer 2011; 47: 530-5.
23. van Sandick J W, Gisbertz S S, ten Berge I J etal. Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer. Ann Surg 2003; 237: 35-43.
24. Gupta D, Lis C G. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 2010; 9: 69.
25. Isenring E A, Capra S, Bauer J D. Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 2004; 91: 447-52.
26. Odelli C, Burgess D, Bateman L etal. Nutrition support improves patient outcomes, treatment tolerance and admission characteristics in oesophageal cancer. Clin Oncol (R Coll Radiol) 2005; 17: 639-45.
27. Read J A, Beale P J, Volker D H, Smith N, Childs A, Clarke S J. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer 2007; 15: 301-7.
28. Goncalves Dias M C, Fatima Nunes M M, Nadalin W, Waitzberg D L. Nutritional intervention improves the caloric and proteic ingestion of head and neck cancer patients under radiotherapy. Nutr Hosp 2007; 20: 320-5.
29. Ryan A M, Reynolds J V, Healy L etal. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg 2009; 249: 355-63.
30. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002; 122: 1763-70.
31. Gupta V. Benefits versus risks: a prospective audit. Feeding jejunostomy during esophagectomy. World J Surg 2009; 33: 1432-8.
32. Tomaszek S C, Cassivi S D, Allen M S etal. An alternative postoperative pathway reduces length of hospitalization following esophagectomy. Eur J Cardiothorac Surg 2010; 37: 807-13.